Table 3:
Univariate Cox Analysis | Multivariate Cox Analysis | |||
---|---|---|---|---|
Covariate | Hazard Ratio | 95% CI | Hazard Ratio | 95% CI |
Heart-Kidney a at eGFR < 30mL/min/1.73m2 | 0.34 | 0.21 – 0.53 | 0.42 | 0.26 – 0.67 |
Heart-Kidney a at eGFR 30–45mL/min/1.73m2 | 0.31 | 0.14 – 0.70 | 0.29 | 0.13 – 0.65 |
Heart-Kidney a at eGFR > 45mL/min/1.73m2 | 0.95 | 0.44 – 2.08 | 0.68 | 0.30 – 1.54 |
Ageb | 1.00 | 0.99 – 1.01 | `0.99 | 0.99 – 1.01 |
BMIc | 1.04 | 1.02 – 1.07 | 1.04 | 1.01 – 1.06 |
Waitlist durationd | 1.00 | 0.99 – 1.01 | 1.00 | 1.00 – 1.01 |
Inter-transplant periodb | 0.95 | 0.94 – 0.97 | 0.98 | 0.96 – 0.99 |
Female sex | 1.21 | 0.95 – 1.56 | 1.16 | 0.89 – 1.51 |
Recipient race | ||||
White | reference | reference | reference | reference |
Black | 1.30 | 1.01 – 1.68 | 1.10 | 0.85 – 1.43 |
Hispanic | 1.11 | 0.78 – 1.56 | 1.03 | 0.74 – 1.43 |
Others | 0.96 | 0.59 – 1.57 | 0.92 | 0.55 – 1.53 |
Status 1A or Adult Status 1, 2 | 1.32 | 1.01 – 1.72 | 0.61 | 0.39 – 0.96 |
Dialysis prior to transplant | 1.65 | 1.23 – 2.21 | 1.80 | 1.34 – 2.43 |
Recipient diabetes | 1.37 | 1.07 – 1.74 | 1.26 | 0.97 – 1.64 |
Recipient cerebrovascular disease | 0.87 | 0.48 – 1.57 | 0.77 | 0.43 – 1.39 |
Recipient history of malignancy | 0.84 | 0.56 – 1.25 | 0.86 | 0.56 – 1.31 |
Inotrope dependency | 1.44 | 1.16 – 1.79 | 1.16 | 0.93 – 1.43 |
Medical condition | ||||
Home | reference | reference | reference | reference |
Hospitalized, non-ICU | 1.08 | 0.77 – 1.51 | 1.27 | 0.82 – 1.97 |
ICU | 1.69 | 1.30 – 2.21 | 1.55 | 0.92 – 2.60 |
Ventricular assist device | 1.44 | 0.93 – 2.22 | 0.97 | 0.66 – 1.43 |
Intra-aortic balloon pump | 1.53 | 1.07 – 2.20 | 1.31 | 0.94 – 1.81 |
Functional Status | ||||
Mild limitation | reference | reference | reference | reference |
Moderate limitation | 1.88 | 1.23 – 2.86 | 1.83 | 1.19 – 2.81 |
Severe Limitation | 2.10 | 1.42 – 3.12 | 1.40 | 0.89 – 2.21 |
Donor ageb | 1.02 | 1.01 – 1.02 | 1.02 | 1.01 – 1.03 |
Donor diabetes | 1.12 | 0.63 – 2.00 | 0.95 | 0.48 – 1.90 |
Donor hypertension | 1.62 | 1.18 – 2.21 | 1.38 | 0.95 – 2.01 |
Sex mismatch | 1.12 | 0.89 – 1.42 | 1.15 | 0.86 – 1.55 |
Size mismatch (donor/recipient PHM ratio < 0.86) | 0.77 | 0.50 – 1.16 | 0.58 | 0.38 – 0.89 |
Donor inotropic support | 0.92 | 0.75 – 1.12 | 0.97 | 0.77 – 1.21 |
Donor LVEF < 50% | 1.11 | 0.56 – 2.21 | 0.96 | 0.44 – 2.11 |
Ischemic timee | 1.12 | 1.01 – 1.23 | 1.14 | 1.02 – 1.27 |
Comparisons made to isolated heart retransplant
per 1-year increase
per 1-unit increase;
per 1-day increase
per 1-hour increase
eGFR=estimated glomerular filtration rate; BMI=body mass index; ICU=intensive care unit; PHM=predicted heart mass; LVEF= left ventricular ejection fraction